In Drosophila collections of green fluorescent protein (GFP) trap lines have been used to probe the endogenous expression patterns of trapped genes or the subcellular localization of their protein products. Here, we describe a method, based on non-overlapping, highly specific, shRNA transgenes directed against GFP that extends the utility of these collections to loss-of-function studies. Furthermore, we used a MiMIC transposon to generate GFP traps in Drosophila cell lines with distinct subcellular localization patterns, which will permit high-throughput screens using fluorescently tagged proteins. Finally, we show that fluorescent traps, paired with recombinant nanobodies and mass spectrometry, allow the study of endogenous protein complexes in Drosophila.
Introduction
A commonly used method to visualize endogenous proteins without the need for specific antibodies is the "protein trap" approach (Gossler et al. 1989; Morin et al. 2001; Clark et al. 2011) . Protein trapping relies on transposons that harbor a fluorescent or epitope tag flanked by splice acceptor and donor sites. If such a transposon is inserted into an intron, then its tag is spliced into the open reading frame (ORF) of the trapped gene. This approach has been used successfully in a number of model organisms, including Drosophila, where several collections of GFP-trapped fly lines have become available over the years (Morin et al. 2001; Clyne et al. 2003; Buszczak et al. 2007; Quiñones-Coello et al. 2007; Rees et al. 2011; flytrap.med.yale.edu; www.flyprot.org) .
GFP traps have mainly been used to study the endogenous expression patterns of trapped genes or the subcellular localization of their protein products. Here, we show that the GFP tag can also be used to interfere with gene function by RNAi-mediated knockdown of the tagged transcripts. This method, which we refer to as "tag-mediated loss-of-function," addresses major shortcomings of the classical RNAi approach in which gene-specific sequences are targeted. Furthermore, we show that the GFP tag can be used to efficiently purify endogenous protein complexes for mass spectrometric analysis using recombinant nanobodies against GFP. Finally, we screen for mCherry traps in Drosophila cultured cells and describe several lines with mCherry expression in specific subcellular patterns for use in highthroughput screening.
Materials and Methods

Fly strains
The following protein traps were described in ): dlg1-GFP (CC01936), Spt6-GFP (CA07692), Cp1-GFP (CC01377), Pabp2-GFP (CC00380). Additional protein traps used in this study are listed in Figure S1 . nanos-GAL4 was described by Van Doren et al. (1998) and matα4-tub-GAL4 (also known as mat67) is a gift from D. St Johnston. EGFP-shRNA constructs #1, #2 and #3 were generated by annealing the oligos listed in Table S2 and cloning them into the pVALIUM20 or pVALIUM22 vectors (Ni et al. 2011) using NheI and EcoRI. Transgenic flies were established using the attP40 and attP2 landing sites (Groth et al. 2004; Markstein et al. 2008) . The Spt6-specific shRNA (HMS00364) was obtained from the TRiP at Harvard Medical School.
Fluorescently tagged baits were immunoprecipitated from embryos expressing a GFP-tagged par-6 rescue construct in a par-6 null mutant background (Wirtz-Peitz et al. 2008 ; referred to as par-6 GFP ) or from sgg-YFP (CPTI-002603) obtained from the Drosophila Genetic Resource Center, and w − embyros were used as controls. All tag-mediated loss-of-function experiments in the germline were controlled by driving EGFPshRNAs in the background of the heterozygous GFP trap. The observed phenotypes were invariably wildtype, indicating that the targeted genes are neither haploinsufficient nor subject to transitive RNAi effects, i.e., targeting the GFP exon does not give rise to secondary siRNAs directed against other regions of the transcript (Roignant 2003) . Embryos analyzed in Figure 2B were from the following cross: par-6 GFP ; mat67 / UAS-EGFP-shRNA × par-6 GFP / Y; UAS-EGFP-shRNA. The par-6 GFP ; mat67 stock served as the control in Figure 2A .
Immunofluorescence
The following antibodies were used: rabbit anti-Vasa (1:500; Santa Cruz, sc-30210), rabbit anti-GM130 (Abcam, ab30637), rabbit anti-Anillin (1:1300; a gift of Tim Mitchison), rat anti-troponin H (1:500), mouse anti-1B1 (1:2; Developmental Studies Hybridoma Bank), rabbit anti-cleaved caspase (1:100; Cell Signaling), rabbit anti-GFP (1:500; Abcam, ab6556), mouse anti-Dlg (1:100; Developmental Studies Hybridoma Bank, 4F3). Immunohistochemistry in ovaries was performed as previously described (Neumüller et al. 2008) . Embryos were fixed in 4% (v/v) formaldehyde in PBS/heptane, devitellinized using heptane/methanol, and blocked in 2% (v/v) NGS in PBS, 0.1% (v/v) Triton X-100. Images were acquired on either a Leica TCS SP2 or a Zeiss LSM 710 confocal microscope.
Immunoprecipitation from embryos and mass spectrometry
Overnight collections were extracted with lysis buffer (25 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM EDTA, 1% 5% [v/v] glycerol, 1 mM DTT, 1× Halt Protease and Phosphatase Inhibitor Cocktail [Thermo Scientific]) and debris was removed by centrifuging twice at 1,200 × g for 5 min. Extracts were cleared by incubation with agarose resin (Thermo Scientific) for 1 h at 4 °C, followed by centrifugation at 15,000 × g for 15 min. Immunocomplexes were formed by incubation for 2 h at 4 °C with the following antibodies: anti-GFP nanobodies coupled to agarose beads (10 μL of packed beads per IP; ChromoTek, GFP-Trap_A), rabbit anti-GFP antibodies (5 μL per IP; used in Figure 2 , C-E; Invitrogen, A6455) precipitated using Protein A/G agarose (Thermo Scientific), rabbit anti-GFP antibodies (1 μL per IP; used in Figure S2 , A and B; Abcam, ab6556), rabbit anti-GFP antibodies coupled to sepharose beads (10 μL of packed beads per IP; used in Figure 2F , Figure S2 , C and D; Abcam, ab69314). The immunocomplexes were washed 4× with lysis buffer, eluted in IgG Elution Buffer (Thermo Scientific), and neutralized using 100 mM Tris-HCl (pH 9). The eluates were Western blotted using standard protocols or stained using the PageSilver Silver Staining Kit (Thermo Scientific). The following antibodies were used in Western blotting: rabbit anti-GFP (1:500; Abcam, ab6556), rabbit anti-PKCζ (1:500; Santa Cruz, sc-216), mouse anti-α-tubulin (1:1000; Sigma-Aldrich, T6199).
For mass spectrometry the immunocomplexes were washed 3× with 10 mM Tris-HCl (pH 7.5) prior to elution in order to remove detergent. The neutralized eluate was reduced with 5 mM DTT for 30 min at 56 °C and alkylated with 15 mM iodacetamide for 30 min at RT. The alkylation reaction was quenched with 15 mM DTT. The alkylated eluate was digested with 1 μg of Sequencing Grade Modified Trypsin (Promega) in 2 mM CaCl 2 overnight at 37 °C. The digest was purified on PepClean C-18 Spin Columns (Thermo Scientific) according to the manufacturer's instructions, dried in a SpeedVac, and reconstituted in 10 μL of 2% (v/v) acetonitrile, 0.1% formic acid, of which 4 μL were injected into the mass spectrometer. LC-MS/MS analysis was performed essentially as described (Dephoure and Gygi 2011) . Peptide spectral matches were filtered to a 2% false discovery rate (FDR).
Immunoprecipitation from cell lines and mass spectrometry
Cells were extracted by incubation in lysis buffer (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.5 mM EDTA, 0.5% [v/v] NP-40, 1 mM PMSF, 1× Complete Protease Inhibitor Cocktail [Roche]) for 30 min on ice. The extract was cleared by centrifugation at 20,000 × g for 10 min at 4 °C. mCherry was immunoprecipitated using anti-DsRed nanobodies coupled to agarose beads (ChromoTek, RFP-Trap_A) according to the manufacturer's instructions. The immunoprecipitate was prepared for mass spectrometry and analyzed by LC-MS/MS essentially as described (Sowa et al. 2009; Dephoure and Gygi 2011) . Peptide spectral matches were filtered to a 1% FDR.
Generation of mCherry cell lines
mCherry trap cassettes were amplified from pBS-KS-attB1-2-PT-SA-SD-0-mCherry, pBS-KS-attB1-2-PT-SA-SD-1-mCherry, pBS-KS-attB1-2-PT-SA-SD-2-mCherry (Venken et al. 2011 ) using the primers SA-M-SD-General-NotI-F (AAGGAAAAAAGCGGCCGCAGTCGATCCAACATGGCGAC) and SA-M-SD-General-EcoRI-R (CCGGAATTCAGAAGTTCAAATGGGCTTTC) and subcloned into pMiLRattP1-2 (Venken et al. 2011 ), a mini-Minos transposon containing both Minos inverted repeats and two inverted attP sites for C31 recombinase-mediated cassette exchange. The resulting plasmid, pGTC, had the following structure: MiL-attP1-SA-mCherry-SD-attP2-MiR.
Drosophila S2R+ cells were transfected with the pCoB plasmid and blasticidin-resistant cells were selected with 25 μg/mL of blasticidin one day post-transfection. Resistant cells were cotransfected with the mCherry trap vector described above (pGTC) and a Minos transposase helper plasmid (Pavlopoulos et al. 2004 ) in a 1:1 ratio. 3 independently transfected cultures, one for each of the 3 reading frame constructs, were pooled 2 days post-transfection and cultured for 1 week to allow for maximal expression of the mCherry tag. Approximately 10% of the transfected cells scored positive by FACS and more than 2,000 cells, selected from the top 3-5 percentile, were seeded as single cell in 384-well plates. 5x10 6 blasticidin-sensitive feeder cells had been added to the plates to promote the survival of these single cells. The cell clones were cultured for four weeks in the presence of 12.5 μg/mL of blasticidin to suppress proliferation of the feeder cells. Visible colonies were then isolated, progressively expanded to larger culture sizes, and cryopreserved. See Table S1 for a list of cell lines generated in this study. The Minos insertions were mapped by inverse PCR using 0.5 μg of genomic DNA, as described (Bellen et al. 2011) .
Results
Efficient knockdown of protein traps using shRNAs directed against GFP
We sought to establish reagents for knocking down GFP-trapped genes using transgenic RNAi ( Figure  1A ). For this, we opted for small hairpin RNAs (shRNAs) over long double-stranded RNAs (dsRNAs) because of the consistently high efficacy reported for shRNAs in both soma and germline (Ni et al. 2011; Haley et al. 2008 ). In addition, despite the small size of the GFP coding sequence, shRNAs allowed us to design multiple non-overlapping constructs. This provides a choice of constructs if any are found to induce off-target effects in a particular tissue of interest. Consequently, we designed three nonoverlapping shRNAs against the EGFP tag used in the three original Drosophila protein trap screens (Morin et al. 2001; Buszczak et al. 2007; Quiñones-Coello et al. 2007 ). These shRNAs are predicted to also target the EYFP derivative used in a more recent protein trap screen (Rees et al. 2011) . We cloned these shRNAs into UAS vectors optimized for either somatic or germline expression (see Materials and Methods).
To validate the efficacy of these constructs, we used nanos-GAL4 to drive the shRNAs in the background of a GFP trap inserted in the discs large 1 (dlg) gene ( Figure 1B ). Germline-specific expression of the EGFP-shRNAs in females resulted in the loss of Dlg-GFP signal in the germline, whereas the cortical signal remained unaffected in the somatic follicle cells. To extend these observations, we tested a total of 12 additional GFP traps and consistently observed germline-specific loss of GFP signal upon EGFP-shRNA expression using nanos-GAL4 ( Figure S1A ; data not shown). Importantly, expression of these EGFP-shRNAs in the germline using either nanos-GAL4 or matα4-tub-GAL4 had no adverse effect on germline development as judged from normal differentiation of germaria and egg chambers as well as normal fertility ( Figure 1B ; data not shown). We conclude that our EGFP-shRNA lines are effective and specific in knocking down GFP-trapped genes in the female germline.
Tag-mediated loss-of-function reveals a role for Spt6 in germline stem cell maintenance
To showcase the utility of these shRNAs in genetic screening, we used them to knock down homozygous viable GFP traps available from the Carnegie collection ) that showed strong GFP signal in female germline stem cells (GSCs) ( Figure S1A ; data not shown). Among these, CA07692 (an insertion in Spt6) was expressed at variable levels throughout oogenesis ( Figure 1C ). The Spt6-GFP signal overlapped with the nuclear DAPI signal, consistent with a recent study implicating Spt6 in transcriptional elongation in Drosophila (Ardehali et al. 2009 ). The 1B1 antibody, which labels spectrosomes and fusomes, and the Vasa antibody, which labels all germline cells, allowed us to correlate Spt6-GFP expression with specific cell types in the germarium. We found that Spt6-GFP was strongly expressed in GSCs adjacent to the stem cell niche (identified as Vasa-positive cells containing a single spectrosome), while lower expression levels were observed in the transit-amplifying cystocytes (distinguished by the presence of a fusome) ( Figure 1C ).
To assess whether Spt6 is required in GSCs, we used nanos-GAL4 to drive individual EGFP-shRNAs in the background of the Spt6-GFP trap. In contrast to wildtype ovaries, where Vasa-positive germline cells are detected in egg chambers of all stages, tag-mediated knockdown of Spt6-GFP using three nonoverlapping EGFP-shRNAs resulted in the depletion of Vasa-positive cells from the germline with only somatic cells remaining in the ovaries ( Figure 1D ). This, together with the finding that knockdown of Spt6 did not trigger apoptosis in the germline (data not shown), suggests that Spt6 is required for GSC maintenance, which is consistent with recent findings that transcriptional elongation is an important regulatory event in stem cell homeostasis (Bai et al. 2010; Neumüller et al. 2011) . We corroborated these data using a gene-specific shRNA against Spt6, which caused a similar phenotype when expressed in the germline ( Figure S1C ).
Tag-mediated loss-of-function identifies genes required for germ cell survival
Another trap identified in our tag-mediated loss-of-function screen was CC01377, an insertion in Cysteine proteinase-1 (Cp1), which is expressed at all stages of oogenesis and accumulates predominantly at the fusome in germaria and in the oocytes of developing egg chambers ( Figure 1E ). Knockdown of Cp1 using two independent EGFP-shRNAs resulted in egg chambers with fewer Vasa-positive germline cells compared to wildtype (Figure 1 , F and G; Figure S1D ). To identify the underlying cause we stained for caspase cleavage as a marker for apoptosis. Whereas cleaved caspase-positive cells were rarely observed in the wildtype germline, we detected a high frequency of apoptotic germline cells upon Cp1 knockdown ( Figure 1G ). The highest incidence of caspase cleavage was observed in cystocytes (region 2 of the germarium), but apoptotic cells were also detected at later stages of oogenesis. Interestingly, apoptotic cells were not detected in region 1 of the germarium, consistent with our observation that ovaries still contained germline cells in 4 day-old flies.
A third trap identified in our screen is CC00380, an insertion in polyA-binding protein II (Pabp2). Tag-mediated knockdown of Pabp2 using two independent EGFP-shRNAs resulted in almost complete loss of germline cells ( Figure 1I and Figure S1D ). The few remaining germline cells showed signs of nuclear fragmentation (data not shown) and stained positive for cleaved caspase ( Figure 1I ), suggesting that Pabp2 is required for cell survival across the germline. Consistent with this, Pabp2-GFP was uniformly expressed in the germline ( Figure 1H ). Our findings are also consistent with a study reporting that flies mutant for a hypomorphic allele of Pabp2 are sterile and contain degenerating egg chambers arresting at stage 8 of oogenesis (Benoit et al. 2005) . The stronger phenotype observed upon tag-mediated knockdown most likely reflects a null or strongly hypomorphic phenotype. Taken together, our tagmediated knockdown screen revealed a requirement for both Cp1 and Pabp2 in cell survival in the germline, with Cp1 fulfilling this function mostly at the cystocyte stage of oogenesis.
Tag-mediated loss-of-function in the embryo
Our functional analysis of Spt6, Cp1, and Pabp2 in the female germline indicates that tag-mediated knockdown is a powerful strategy to study phenotypes with a high degree of stringency. Besides inducing phenotypes in the germline, shRNAs have been used to deplete the maternal contribution of proteins required in embryogenesis (Ni et al. 2011) . To test if our EGFP-shRNAs are effective in inducing embryonic phenotypes we turned to par-6, a gene required for the establishment of epithelial polarity. While embryos derived from par-6 homozygous mutant germline clones (par-6 GLC ) show an embryonic lethal defect in cell polarity, the zygotic mutant mostly survives to the larval stage owing to the maternal contribution of Par-6 protein (Petronczki and Knoblich 2001) . We used matα4-tub-GAL4 to drive one of our EGFP-shRNAs in par-6 mutant females expressing a GFP-tagged genomic rescue construct (par-6 GFP ) (Wirtz-Peitz et al. 2008 ) and analyzed the resulting embryos using antibodies against Dlg and GFP. The ectodermal epithelium of control embryos was organized as a monolayer, and its constituent cells showed a columnar morphology (Figure 2A ). In contrast, epithelial cells in RNAi embryos had rounded up and formed an irregular, multilayered, epithelium ( Figure 2B ), as has been reported for par-6 GLC embryos (Petronczki and Knoblich 2001) .
Furthermore, in control embryos Dlg was confined to the basolateral cell cortex, whereas Par-6-GFP was localized to the sub-apical region (Figure 2A ). In RNAi embryos lacking Par-6-GFP, Dlg was localized all around the cell cortex except in the outermost cells ( Figure 2B) . Therefore, the EGFP-shRNA directed against par-6-GFP closely phenocopies the epithelial defects in par-6 GLC embryos.
Using fluorescently tagged genes to isolate endogenous protein complexes
Par-6 assembles a well-defined complex with two other proteins, atypical protein kinase C (aPKC) and Lethal (2) giant larvae (Lgl) (Betschinger et al. 2003) . This led us to explore if GFP-tagged fly lines could be used to analyze endogenous protein complexes when combined with recently commercialized highaffinity GFP antibodies raised in llamas (Rothbauer et al. 2006 (Rothbauer et al. , 2008 . These so-called nanobodies lack light chains, which allows the heavy chain's variable domain to be cloned and purified to high titer from a recombinant source. Thus, these antibodies promise to combine the high antigen-binding capacity of polyclonal sera with the specificity of monoclonal antibodies.
To test this we used anti-GFP nanobodies to immunoprecipitate Par-6 from par-6 GFP embryos.
Western blotting showed that Par-6-GFP was immunoprecipitated and its binding partner aPKC was coimmunoprecipitated from these embryos by both nanobodies and a polyclonal control serum ( Figure 2D ). However, in contrast to the control antibodies, the nanobodies completely depleted Par-6 from the extract after as little as 60 min of incubation and even partially depleted its binding partner aPKC ( Figure 2C and Figure S2 , A and B). Although Par-6-GFP is only weakly expressed as inferred from its comparatively faint fluorescence (data not shown), the Par complex containing Par-6, Lgl, and aPKC was clearly detected on a silver-stained gel in immunoprecipitates from ~200 μL of packed embryos ( Figure 2E ). In addition, these proteins were readily identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) after in-solution digestion of the immunoprecipitate ( Figure 2F and File S1). These proteins were also identified when Par-6-GFP was immunoprecipitated using agarose-coupled polyclonal control antibodies, albeit with significantly lower peptide coverages. In fact, Stardust, which so far could only be shown to bind Par-6 when both proteins were overexpressed in cultured cells (Hurd et al. 2003) , was specifically identified in the nanobody immunoprecipitate but not in the polyclonal control immunoprecipitate ( Figure 2F and File S1).
To assess the performance of anti-GFP nanobodies with a different bait we turned to a YFP trap in shaggy (Rees et al. 2011) , the Drosophila ortholog for Glycogen synthase kinase 3 and a core subunit of the Armadillo destruction complex (MacDonald et al. 2009 ). Silver staining of the nanobody immunoprecipitate revealed a double band ( Figure S2C ), which in-solution digestion and LC-MS/MS identified as Shaggy and its well-characterized interactor Axin ( Figure S2D ). Although both proteins were also identified using polyclonal control antibodies, the nanobodies recovered a higher amount of bait protein with less background, resulting in superior peptide coverage. Together, these experiments indicate that GFP traps or GFP-tagged genomic rescue constructs can be used in conjunction with anti-GFP nanobodies to interrogate the Drosophila interactome with high sensitivity and stringency.
Extending the protein trap approach to Drosophila cell lines
Although in vivo approaches are strongly preferred for most Drosophila studies, cell lines remain a powerful system for high-throughput RNAi screening. To generate cell lines with fluorescent proteins that label distinct subcellular features for use in such applications, we developed a protein trap approach for Drosophila S2 cells using the MiMIC transposon. MiMIC is a Minos-based protein trap featuring a mutagenic marker cassette containing a splice acceptor site followed by a triple stop (Venken et al. 2011 ). The cassette is flanked by two inverted ΦC31 integrase attP sites that allow its replacement with a sequence of interest by recombinase-mediated cassette exchange (RMCE). As depicted in Figure 3A , we replaced the mutagenic marker cassette with a fluorescent protein trap consisting of the mCherry coding sequence in one of three frames flanked by splice acceptor and donor sites.
This modified MiMIC element was mobilized into random positions in S2R+ cells using a transiently transfected Minos transposase (Metaxakis et al. 2005) . As part of a pilot screen we FACS-sorted more than 2,000 mCherry-positive cells and established approximately 50 stable clones from single cells ( Figure 3A and Table S1 ). In a number of these lines mCherry assumed a distinct subcellular distribution, indicative of a successful trapping event (Figure 3 , B and C; Table S1 ). For example, cell line NPT017 showed a cell cycle-dependent localization of mCherry, being distributed diffusely in the cytoplasm at interphase and relocalizing to the cleavage furrow at cytokinesis. In cell line NPT005, by contrast, mCherry was localized to cytoplasmic puncta, which partially overlapped with BiP, a marker for the endoplasmic reticulum (Otero et al. 2010 ; Figure 3C ).
To identify the gene trapped in NPT005 we purified the mCherry-tagged protein using anti-DsRed nanobodies followed by LC-MS/MS of the in-solution digested immunoprecipitate. This identified Chloride intracellular channel (Clic) as the highest-ranked protein hit ( Figure 3D ), and inverse PCR-based mapping of the MiMIC insertion site confirmed Clic as the trapped gene (data not shown). Using the same strategy we identified atx2 and gap1 as the genes trapped in NPT022 and NPT102, respectively (Table S1 ; data not shown).
Finally, as proof-of-principle for RMCE in these cell lines we successfully swapped mCherry for EGFP in NPT101 and NPT102 by cotransfection of an EGFP donor cassette along with ΦC31 integrase ( Figure 3E ). Taken together, these data demonstrate that the MiMIC transposon can be used to trap specific genes in Drosophila cell lines, and that stable clones of such traps may be established for use in diverse applications ranging from imaging to biochemical studies.
Discussion
Advantages of tag-specific over gene-specific knockdown
Here, we have described a set of validated shRNA constructs for tag-mediated loss-of-function in GFP trap lines. This method addresses two major challenges in screens based on gene-specific RNAi constructs. First, gene-specific constructs may cause off-target effects, which manifest as false positives in RNAi screens (Ma et al. 2006; Kulkarni et al. 2006; Dietzl et al. 2007 ). Off-target effects can be controlled by rescue of the RNAi phenotype using an RNAi-resistant construct, but such transgenes are not readily available and need to be generated on a gene-by-gene basis (Mohr et al. 2010) . By contrast, the shRNA used for tag-mediated knockdown can be expressed in the target tissue in the absence of a GFP trap to exclude the possibility of unspecific phenotypes.
Second, the efficacy of gene-specific RNAi constructs varies widely, with ineffective constructs giving rise to false-negatives in RNAi screens (Dietzl et al. 2007; Booker et al. 2011) . While the falsenegative rate may be lowered by targeting each gene with two or more independent RNAi constructs (Mohr et al. 2010) , the use of a single optimized shRNA in tag-mediated knockdown ensures consistently high efficacy. In addition, the degree of knockdown is readily verified by monitoring GFP fluorescence in the target tissue. GFP-mediated knockdown is therefore a compelling method to remove artifacts and ambiguity from RNAi experiments.
Strategies for isolating endogenous protein complexes
Analogous to gene-specific RNAi reagents in functional studies, biochemical studies of protein-protein interactions typically rely on protein-specific antibody reagents. Because these are time-consuming and expensive to raise and recognize their protein antigen with widely variable specificity and affinity, an alternative approach is to ectopically express epitope-tagged baits, which may then be immunoprecipitated using monoclonal antibodies. However, if such constructs are not expressed at endogenous levels or in the proper spatial patterns, then this is predicted to increase the occurrence of false-positive interactors, currently a major challenge of such studies (Gingras et al. 2007) . By contrast, the use of GFP traps permits the purification of endogenously expressed protein complexes using a single validated antibody reagent, thereby combining the advantages of both methods.
In addition, our data suggest that the favorable binding properties of GFP-specific nanobodies offset the low endogenous expression levels of many proteins and permit the mass spectrometric detection of even weak interactions. Interestingly, neither the interaction between Par-6 and Lgl or Stardust, nor the interaction between Shaggy and Axin were reported in a recent S2 cell-based co-immunoprecipitation study (Guruharsha et al. 2011) , suggesting that many critical interactions are only detected by in vivo assays. Our data, together with another recent study on protein complexes purified from protein traps (Rees et al. 2011) , provide an experimental framework for analyzing physical interactions between endogenous proteins in Drosophila.
Perspectives for fluorescent protein trapping in Drosophila
Although it is estimated that approximately 3,200 Drosophila genes are permissive to protein trapping by conventional P element and piggyBac transposons, only a few hundred Drosophila genes have so far been tagged with a transgenic GFP trap (Aleksic et al. 2009 ). Among these, three classes of traps need to be distinguished. First, insertions that disrupt protein function and are thus homozygous lethal. These traps are not amenable to tag-mediated knockdown, owing to the absence of transitive RNAi in Drosophila (see Materials and Methods), and they are similarly unsuitable for biochemical analysis because a tag which disrupts a protein's activity may also interfere with its physical interactions. Second, insertions spliced into only some of a gene's transcripts (Quiñones-Coello et al. 2007 ). Such traps have been used to analyze the distribution of cell type-specific isoforms (Silies and Klämbt 2010), and we were able to induce germline phenotypes by tag-mediated knockdown of isoform-specific traps. At the same time, we have also encountered a number of lines in which the expression of an unaffected splice form masked the tag-mediated knockdown of the trapped transcripts (data not shown). Finally, the third class comprises homozygous viable insertions that trap all of a gene's transcripts and which are generally the most useful.
While the genome coverage of usable protein traps remains limited, a large-scale effort is currently ongoing to generate over 6,000 insertions using the MiMIC transposon (Venken et al. 2011) . Although these traps will need to be individually converted to GFP traps by RMCE, we anticipate that the methods described by us, as well as the traditional utility of the GFP tag in localization studies, will drive the conversion of a large number of these lines. At the same time, improved methods for generation of GFP knockins (Huang et al. 2009 ) and the generation of GFP-tagged genomic rescue constructs by individual investigators or as part of high-throughput projects (Venken et al. 2006; Ejsmont et al. 2009 ) is expected to increase genome coverage. Such targeted methods will also allow tagging of genes refractory to protein trapping (e.g., intronless genes). Finally, we consider the methods described here applicable to other model systems, for example to haploid cell lines, which appear uniquely suited to gene trapping and tagmediated knockdown (Debec 1978; Carette et al. 2009 ).
Note: While our manuscript was under review, Pastor-Pareja and Xu (2011) independently described loss-of-function phenotypes by RNAi-mediated knockdown of GFP in protein trap lines. While our approach is conceptually similar to theirs, the use of shRNA constructs rather than a long dsRNA construct lends added flexibility and stringency to this method. First, shRNAs permit the induction of phenotypes in the female germline and in the embryo, where dsRNAs have proven ineffective (Ni et al. 2011) . Second, the availability of multiple non-overlapping constructs allows phenotypes to be validated with an independent shRNA. 
